TACHYARRHYTHMIAS IN PATIENTS WITH CANCER

E G Chelombit'ko , S V Korolev , A V Konev , E V Plokhova , D P Doundoua

Journal of Clinical Practice ›› 2017, Vol. 8 ›› Issue (4) : 76 -89.

PDF
Journal of Clinical Practice ›› 2017, Vol. 8 ›› Issue (4) : 76 -89. DOI: 10.17816/clinpract8476-89
Articles
review-article

TACHYARRHYTHMIAS IN PATIENTS WITH CANCER

Author information +
History +
PDF

Abstract

Arrhythmia is often detected in cancer patient, from single ventricular premature contractions to sustained ventricular tachycardia, life threatening ventricular fibrillation and sudden cardiac death. Oncology per se, aggressive anticancer treatment, both chemotherapy and radiation and basic cardiac conditions are main causative factors for tachyarrhythmia. In this review we summarize evidence of arrhythmia and emphasize the importance of cardiac monitoring for the early diagnosis, intervention and surveillance of those patients more susceptible to develop proarrhythmia. Oncologists should be fully aware of arrhythmia and the close collaboration between cardiologists and oncologists would result in a better cardiovascular assessment, risk stratification, cardiac monitoring and treatment.

Keywords

tachyarrhythmia / oncology / chemotherapy / arrhythmogenic action / supraventricular tachycardia / ventricular tachycardia / cardiooncology / cardiotoxicity

Cite this article

Download citation ▾
E G Chelombit'ko, S V Korolev, A V Konev, E V Plokhova, D P Doundoua. TACHYARRHYTHMIAS IN PATIENTS WITH CANCER. Journal of Clinical Practice, 2017, 8(4): 76-89 DOI:10.17816/clinpract8476-89

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

Chelombit'ko E.G., Korolev S.V., Konev A.V., Plokhova E.V., Doundoua D.P.

AI Summary AI Mindmap
PDF

32

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/